Biolife Solutions (BLFS) Debt to Equity (2016 - 2025)
Biolife Solutions (BLFS) has disclosed Debt to Equity for 13 consecutive years, with $0.01 as the latest value for Q4 2025.
- On a quarterly basis, Debt to Equity fell 70.59% to $0.01 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.01, a 70.59% decrease, with the full-year FY2025 number at $0.01, down 70.59% from a year prior.
- Debt to Equity was $0.01 for Q4 2025 at Biolife Solutions, down from $0.02 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.07 in Q1 2024 to a low of $0.01 in Q1 2021.
- A 5-year average of $0.04 and a median of $0.04 in 2024 define the central range for Debt to Equity.
- Peak YoY movement for Debt to Equity: skyrocketed 371.77% in 2022, then crashed 70.59% in 2025.
- Biolife Solutions' Debt to Equity stood at $0.02 in 2021, then soared by 371.77% to $0.07 in 2022, then decreased by 0.82% to $0.07 in 2023, then plummeted by 35.31% to $0.05 in 2024, then plummeted by 70.59% to $0.01 in 2025.
- Per Business Quant, the three most recent readings for BLFS's Debt to Equity are $0.01 (Q4 2025), $0.02 (Q3 2025), and $0.03 (Q2 2025).